Frequently Asked Questions

Q: What is the HeatStroke Kit Test?

A: The HeatStroke Kit Test is a research-use diagnostic tool designed to detect early signs of kidney stress caused by heat stroke and dehydration. It measures L-FABP (Liver-type Fatty Acid Binding Protein) in urine, enabling timely intervention to prevent acute kidney injury (AKI) and long-term kidney damage.

Q: What is L-FABP?

A: L-FABP is a low molecular weight soluble protein (14 kDa) specifically expressed in the liver and renal proximal tubules. Under conditions like renal tubular ischemia and oxidative stress, L-FABP is excreted into urine, making it a useful marker for early diagnosis of renal diseases associated with tubular dysfunction.

Q: How does the HeatStroke Kit Test work?

A: The test detects L-FABP in urine, which is released from kidney tubular cells under stress. Elevated levels indicate kidney stress before symptoms appear, allowing for early intervention to prevent serious complications.

Q: Who should use this test?

A: The kit is intended for research use with populations exposed to extreme heat, including:

  • Military personnel
  • Construction workers
  • Oil & gas field staff
  • Logistics personnel
  • Event organizers
  • CSR/ESG divisions of conglomerates

It is not for home or clinical diagnostic use.

Q: How long does the test take?

A: The assay time is approximately 2 hours, from sample collection to result interpretation.

Q: How is the urine sample collected?

A: A standard urine sample is collected in a clean container and added to the test according to the kit instructions. No special preparation is needed.

Q: Can the test prevent kidney damage?

A: The kit cannot prevent damage directly, but by detecting stress early, it allows researchers, safety officers, and healthcare teams to implement interventions (hydration, rest, medical monitoring) that reduce the risk of AKI and long-term complications.

Q: What conditions can affect the test results?

A:

  • Severe dehydration or recent intense heat exposure may affect L-FABP levels.
  • Certain medications or underlying kidney conditions may influence readings.
  • Results should always be interpreted within the context of research protocols or occupational health guidelines.

Q: Is this test FDA or CE approved?

A: The HeatStroke Kit Test is for research use only. It is not approved for clinical diagnosis or treatment decisions.

Q: Where can I learn more about L-FABP and heat-related kidney injury?

A: For research and clinical references, see peer-reviewed publications on L-FABP as an early biomarker of kidney stress and studies on heat stroke-related acute kidney injury (AKI). Your kit supplier can provide a curated list of key studies.